A detailed history of Delta Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Delta Asset Management LLC holds 1,016 shares of AMGN stock, worth $267,594. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,016
Previous 1,096 7.3%
Holding current value
$267,594
Previous $342,000 4.39%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$309.38 - $337.38 $24,750 - $26,990
-80 Reduced 7.3%
1,016 $327,000
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $7,159 - $8,076
-28 Reduced 2.49%
1,096 $315,000
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $1,580 - $1,926
-7 Reduced 0.62%
1,124 $271,000
Q3 2022

Nov 09, 2022

SELL
$224.46 - $253.15 $10,774 - $12,151
-48 Reduced 4.07%
1,131 $255,000
Q3 2021

Nov 03, 2021

SELL
$212.27 - $248.7 $64,530 - $75,604
-304 Reduced 20.5%
1,179 $251,000
Q2 2021

Aug 02, 2021

SELL
$233.58 - $259.14 $166,542 - $184,766
-713 Reduced 32.47%
1,483 $361,000
Q4 2020

Feb 02, 2021

BUY
$216.38 - $257.67 $11,035 - $13,141
51 Added 2.38%
2,196 $505,000
Q2 2020

Jul 23, 2020

SELL
$197.81 - $242.74 $18,791 - $23,060
-95 Reduced 4.24%
2,145 $506,000
Q1 2020

Apr 27, 2020

BUY
$182.24 - $241.7 $37,359 - $49,548
205 Added 10.07%
2,240 $454,000
Q4 2018

Feb 08, 2019

BUY
$178.4 - $208.25 $31,220 - $36,443
175 Added 9.41%
2,035 $396,000
Q3 2018

Oct 22, 2018

SELL
$185.29 - $208.89 $32,425 - $36,555
-175 Reduced 8.6%
1,860 $386,000
Q2 2018

Jul 23, 2018

BUY
$166.05 - $186.51 $86,346 - $96,985
520 Added 34.32%
2,035 $376,000
Q1 2018

Apr 26, 2018

BUY
$169.43 - $198.0 $67,772 - $79,200
400 Added 35.87%
1,515 $258,000
Q4 2017

Jan 23, 2018

BUY
$168.79 - $188.59 $13,503 - $15,087
80 Added 7.73%
1,115 $194,000
Q3 2017

Oct 26, 2017

BUY
$167.29 - $191.0 $173,145 - $197,685
1,035
1,035 $193,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Delta Asset Management LLC Portfolio

Follow Delta Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Asset Management LLC with notifications on news.